India plans to audit clinical trials

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1204-c (Published 17 November 2005) Cite this as: BMJ 2005;331:1204

This article has a correction. Please see:

  1. Biju Basil (bijubasil@yahoo.com), resident in psychiatry1,
  2. Maju Mathews, assistant professor in psychiatry2,
  3. Jamal Mahmud, chief resident in psychiatry2,
  4. Babatunde Adetunji, attending psychiatrist3,
  5. Kumar Budur, attending psychiatrist4
  1. 1Drexel University College of Medicine, Philadelphia, PA 19124 USA,
  2. 2Drexel University College of Medicine, Philadelphia, PA 19124 USA,
  3. 3MHM Correctional Services, Philadelphia, PA 19102
  4. 4Cleveland Clinic Foundation, Cleveland, OH 44195, USA

    EDITOR—Regulation of clinical trials by India's government is an essential step towards protecting the interests of the poor, uneducated, and gullible public of India from being made unsuspecting human guinea pigs for the rich and powerful global healthcare industry.1 This measure needs to be emulated by the governments of other developing countries and the World …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription